• FDA Approves First Combination Pill to Treat Hepatitis C
    The Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection. Harvoni is the first combination pill approved to treat chronic HCV genotype 1 infection. It is also the first approved regimen ...More
    2 weeks ago Posted in News
  • Genetic 'Instruction Set' for Antibodies Knocks Out Hepatitis C in Mice
    A triple-punch of antibodies both prevented hepatitis C infection and wiped out the disease after it had established itself in laboratory mice, according to a study led by Princeton University researchers. Instead of delivering the three antibodies directly, the researchers ...More
    4 weeks ago Posted in News
  • SLU Researcher to Study New Hepatitis C Medication in Children
    After the success of a new drug treatment in adults with hepatitis C infection, a Saint Louis University pediatric researcher is testing the safety and efficacy of the medications in children. Part of a multi-center clinical study, SLU is the only center in the region that ...More
    4 weeks ago Posted in News
  • T-Bet Protein Tackles Hepatitis
    A single protein may tip the balance between ridding the body of a dangerous virus and enduring life-long chronic infection, according to a report appearing in the Journal of Experimental Medicine. ...More
    September 15, 2014 Posted in News
  • IDSA, HIVMA Call for State Medicaid Programs to Lift Hepatitis C Prescribing Restrictions
    At a time when curative treatment is available for hepatitis C (HCV), some state Medicaid programs are instituting harmful barriers to the new HCV treatment, including limiting the availability of physicians to treat this growing epidemic by restricting infectious diseases ...More
    September 9, 2014 Posted in News
  • Model of Viral Lifecycle Could Help in Finding a Cure for Hepatitis B
    A new technique for studying the lifecycle of the hepatitis B virus could help researchers develop a cure for the disease. In a paper published today in the journal Proceedings of the National Academy of Sciences, Sangeeta Bhatia of MIT and Charles Rice of Rockefeller ...More
    August 4, 2014 Posted in News
  • Study Predicts Hepatitis C Will Become a Rare Disease in 22 Years
    Effective new drugs and screening would make hepatitis C a rare disease by 2036, according to a computer simulation conducted by the University of Texas MD Anderson Cancer Center and the University of Pittsburgh Graduate School of Public Health. The results of the ...More
    August 4, 2014 Posted in News
  • Hepatitis C Virus Genotype 1 is Most Prevalent Worldwide
    In one of the largest prevalence studies to date, researchers from the U.K. provide national, regional, and global genotype prevalence estimates for the hepatitis C virus (HCV). Findings published in Hepatology, a journal of the American Association for the Study of Liver ...More
    July 28, 2014 Posted in News
  • New Oral Drug Regimens Cure Hardest-to-Treat Hepatitis C
    Two new pill-only antiviral drug regimens could provide shorter, more effective treatment options with fewer side effects for the majority of patients infected with hepatitis C, even those most difficult to treat, according to the results of two studies published in The ...More
    July 28, 2014 Posted in News
  • 1 in 3,000 Blood Donors in England Infected with Hepatitis E
    The first systematic analysis of hepatitis E virus (HEV) transmission by blood components indicates that about 1 in 3,000 donors in England have HEV in their plasma. The findings, published in The Lancet, suggest that around 1,200 HEV-containing blood components (e.g., red ...More
    July 28, 2014 Posted in News
« Previous12345678910115152Next »